Ginkgo Extract: Clinical Trials

12 trials of Ginkgo Extract, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed, 2 unknown, 1 terminated. 12 Phase 2, 5 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 212Completed 9, Unknown 2, Terminated 1
Phase 15Completed 4, Terminated 1
Phase 31Unknown 1

Follow Ginkgo Extract: new trials by email Literature Review of Ginkgo Extract trials Research Report on Ginkgo Extract

Trials (filtered) newest first · largest first

All 12 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Efficacy of Ginkgo Biloba Extract in the Treatment of Alzheimer's Disease
Ginkgo biloba dispersible tablets, Donepezil, Ginkgo biloba dispersible tablets and Donepezil - Alzheimer's
Phase 2 / Phase 3UnknownThe First Affiliated Hospital with Nanjing Medical University2402016-08-102019-08-07
Safety of Ginkgo Biloba Leaf Extract
Gingko Biloba Extract, Placebo - Healthy
Phase 2UnknownIRCCS San Raffaele662015-07-012016-12-30
Ginkgo Biloba and Ocular Blood Flow in Primary Open-angle Glaucoma
Ginkgo biloba, Placebo to Ginkgo biloba - Glaucoma, Open-Angle
Phase 2CompletedMaisonneuve-Rosemont Hospital192011-08-012015-03-03
Trial of Ginkgo as a Treatment for Cognitive Problems in Multiple Sclerosis
Ginkgo biloba, Placebo - Multiple Sclerosis, Cognitive Ability, General
Phase 2CompletedUS Department of Veterans Affairs1202009-01-012014-06-06
Efficacy and Tolerability of Ginkgo Biloba Extract in Patients With Raynaud´s Phenomenon
Ginkgo biloba extract EGb 761 - Raynaud Disease
Phase 2CompletedVSM Geneesmiddelen b.v.412005-11-012017-05-22
A Pilot Study of Curcumin and Ginkgo for Treating Alzheimer's Disease
Placebo and ginkgo extract, Curcumin and ginkgo extract - Alzheimer's Disease
Phase 1 / Phase 2CompletedChinese University of Hong Kong362004-10-012008-04-30
Ginkgo Biloba to Improve Short-Term Memory Losses Associated With Electroconvulsive Therapy (ECT)
ginkgo biloba, matched placebo - Memory, Short-Term
Phase 1 / Phase 2TerminatedMedical University of South Carolina502003-02-012018-07-18
Ginkgo Biloba: Antidepressant-Induced Sexual Dysfunction
Ginkgo Biloba, Sex Therapy (genital focus) - Hypoactive Sexual Desire Disorder, Sexual Dysfunctions, Psychological
Phase 2CompletedNational Center for Complementary and Integrative Health (NCCIH)2002-06-012006-08-18
Effects of Ginseng and Ginkgo on Drug Disposition in Man
Ginseng, Ginkgo - Healthy
Phase 2CompletedNational Center for Complementary and Integrative Health (NCCIH)602002-03-012006-07-26
Extract of Ginkgo Biloba (EGB 761) and Vascular Function
Gingko Biloba (Herb) - Intermittent Claudication, Peripheral Vascular Disease
Phase 1 / Phase 2CompletedNational Center for Complementary and Integrative Health (NCCIH)1002000-09-012006-08-18
Borage Oil and Ginkgo Biloba (EGb 761) in Asthma
Gingko biloba, Borage oil - Asthma
Phase 1 / Phase 2CompletedNational Center for Complementary and Integrative Health (NCCIH)2802000-09-012006-08-18
Natural Antioxidants in the Treatment of Multiple Sclerosis
Ginkgo biloba, Alpha-lipoic acid, Vitamin E/Selenium - Multiple Sclerosis
Phase 1 / Phase 2CompletedNational Center for Complementary and Integrative Health (NCCIH)1999-09-012006-08-18

Conditions studied

Multiple Sclerosis (2)  ·  Alzheimer Disease (1)  ·  Asthma (1)  ·  Dementia (1)  ·  Drug-Related Side Effects and Adverse Reactions (1)  ·  Genomic Instability (1)  ·  Glaucoma (1)  ·  Glaucoma, Open-Angle (1)  ·  Intermittent Claudication (1)  ·  Neurobehavioral Manifestations (1)  ·  Neurodegenerative Diseases (1)  ·  Peripheral Vascular Diseases (1)  ·  Raynaud Disease (1)  ·  Sexual Behavior (1)  ·  Sexual Dysfunctions, Psychological (1)

Sponsors

National Center for Complementary and Integrative Health (NCCIH) (5)  ·  Chinese University of Hong Kong (1)  ·  IRCCS San Raffaele (1)  ·  Maisonneuve-Rosemont Hospital (1)  ·  Medical University of South Carolina (1)  ·  The First Affiliated Hospital with Nanjing Medical University (1)  ·  US Department of Veterans Affairs (1)  ·  VSM Geneesmiddelen b.v. (1)

Countries

United States (7)  ·  Canada (1)  ·  China (1)  ·  Hong Kong (1)  ·  Italy (1)  ·  Netherlands (1)

Top investigators

Charles H. Kellner, M.D. (1)  ·  Cindy Meston, PhD (1)  ·  Dennis N. Bourdette, MD (1)  ·  Dr. Dennis Bourdette (1)  ·  Ellen Freeman, PhD (1)  ·  John S. Markowitz, PharmD (1)  ·  John W. Farquhar, MD (1)  ·  Larry Baum, PhD (1)  ·  Mark Lesk, MD (1)  ·  Stefano Bonassi, PhD (1)  ·  Thomas W Uhde, MD (1)  ·  Ting Wu (1)

Results publications

PMID 12213959, PMID 16973674, PMID 17951067, PMID 18204357, PMID 18628657, PMID 22955125, PMID 23410167, PMID 23652021, PMID 24184488, PMID 25446328, PMID 28093823, PMID 29357859

NIH funding

P50AT000066 (1), R21AT000939 (1)